Track the Biomed-Lublin Wytwórnia Surowic I Szczepionek SA stock price and the full management transaction log of the company, a listed equity based in Poland. Shares trade on PL PL, under the authority of KNF. Operating in the Health Care sector, Biomed-Lublin Wytwórnia Surowic I Szczepionek SA has published 8 public disclosures. The latest transaction was disclosed on 18 May 2026 (Notification PDMR). Among the most active insiders: Anonymous (PDMR). All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.